Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!
My New Book is Now A Best Seller | Order Now My New Book is Now A Best Seller | Order Now

​Regeneron’s Antibody COVID Treatment Uses an Aborted Fetal Cell Line

  • October 13, 2020

Even though Regeneron’s experimental COVID-19 drug, REGN-COV2, got its start with cells derived from a human fetal cell line, the company says it doesn’t consider the treatment as one relying on fetal tissue. The HEK293T “immortalized” cell lines were acquired from an aborted fetus so long ago — the 1970s — and have been divided and grown in cultures so many times that they’re simply considered “a tool” for research, the company told ABC...